Calyxia, a leading industrial B2B Cleantech innovator, has raised $35 million in a Series B funding round led by Lombard Odier Investment Managers and Bpifrance. The funding will enable Calyxia to achieve profitability, expand its global operations, and establish itself as a leader in the market.
Calyxia’s proprietary technology produces sustainable microparticle and microcapsule products that combine biodegradability, advanced performance, and cost-effectiveness. The company’s products are designed to replace traditional microplastic microcapsules and microparticles, which are being banned by regulators worldwide.
The funding will support Calyxia’s expansion plans, including the establishment of new headquarters and a second production site in the Paris Region by Q1 2025. The company’s CEO, Jamie Walters, said the investment will accelerate the deployment of its products, allowing manufacturers to reduce plastic pollution and GHG emissions while boosting their product performance and profitability.
Industry experts praised Calyxia’s innovative approach, citing its potential to scale and become a leader in the sector. “We believe that Calyxia’s groundbreaking technology offers an innovative approach to tackling microplastic pollution,” said Christopher Tritten, Head of Private Assets and CIO at Lombard Odier Investment Managers.
